Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kim Dijke
Observed name:
K. Dijke
Institutions:
The Netherlands Cancer Institute,
University Medical Center Utrecht
Observed institutions:
Erasmus MC,
The Netherlands Cancer Institute,
University Medical Center Utrecht
ORCID:
0009-0007-3886-4655
Observed ORCID:
0009-0007-3886-4655
OpenAlex ID:
A5086816702
Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort
2022
·
Linda A.J. Hendricks
, Nicoline Hoogerbrugge
, et al.
·
European Journal of Medical Genetics
·
33
PDF
Well-Differentiated Bronchopulmonary Neuroendocrine Tumors: More Than One Entity
2021
·
Medard F.M. van den Broek
, Sonja Levy
, et al.
·
Journal of Thoracic Oncology
·
16
PDF
Health-Related Quality of Life (HRQoL) Assessments in Research on Patients with Adult Rare Solid Cancers: A State-of-the-Art Review
2025
·
Catarina S. Padilla
, Cristiane D. Bergerot
, et al.
·
Cancers
·
15
PDF
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question
2023
·
Kim Dijke
, Koert F.D. Kuhlmann
, et al.
·
Current Oncology Reports
·
6
Survival and prognostic differences between appendiceal NETs and goblet cell adenocarcinomas
2025
·
Kim Dijke
, José van den Berg
, et al.
·
Endocrine Oncology
·
1
37P Survival and prognostic factors in appendiceal neuroendocrine tumours and goblet cell carcinoma
2023
·
K. Dijke
·
ESMO Open
PDF
Show more works
View as search
Works count:
6
Citation count:
71
H-index:
4
I10-index:
3
Year
Topic
Type